Novel findings of our recent paper: Manufacturing mesenchymal stromal cells in a microcarrier-microbioreactor platform can enhance cell yield and quality attributes: case study for acute respiratory distress syndrome’ were featured this week in an exciting article by the Cornell Chronicle, Cornell’s official news source since 1969.

The article, titled: ‘New approach moves cell therapy closer to treating many disorders‘ offers a high-level overview of our findings, highlighting the complex challenges of cell therapy manufacturing and our group’s mission to help move the needle forward.